Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.
about
Characterization of protection afforded by a bivalent virus-like particle vaccine against bluetongue virus serotypes 1 and 4 in sheepBaculovirus-expressed nonstructural protein NS2 of bluetongue virus induces a cytotoxic T-cell response in mice which affords partial protectionCurrent and next-generation bluetongue vaccines: Requirements, strategies, and prospects for different field situations.Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice.Multigene expression of protein complexes by iterative modification of genomic Bacmid DNAContribution of virus-like particles to the immunogenicity of human immunodeficiency virus type 1 Gag-derived vaccines in miceGeneration of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.Multiserotype protection elicited by a combinatorial prime-boost vaccination strategy against bluetongue virus.Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattleDevelopment of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.Rapid generation of replication-deficient monovalent and multivalent vaccines for bluetongue virus: protection against virulent virus challenge in cattle and sheepProspects for improved bluetongue vaccines.Bluetongue vaccines: the past, present and future.Replication-Deficient Particles: New Insights into the Next Generation of Bluetongue Virus Vaccines.Virus-like particle vaccines and adjuvants: the HPV paradigm.Purification, stability, and immunogenicity analyses of five bluetongue virus proteins for use in development of a subunit vaccine that allows differentiation of infected from vaccinated animals.Developments in virus-like particle-based vaccines for infectious diseases and cancer.Virus-like particles produced in plants as potential vaccines.Optimized production of recombinant bluetongue core-like particles produced by the baculovirus expression system.Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.Biological mimicry of the bluetongue virus core protein VP7 by rabbit anti-idiotype.What's going on in vaccine technology?Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity.A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus.The use of risk assessment to decide the control strategy for bluetongue in Italian ruminant populations.VP2-segment sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean basin during the 1998-2003 outbreak.Opinion of the Scientific Panel on Animal Health an Welfare (AHAW) on the EFSA Selfmandate on bluetongue origin and occurrenceNanoparticle Vaccines Against Infectious Diseases
P2860
Q27315250-64A36A25-BF9B-4CEF-BA52-D707C3875EA6Q27477790-B3E5AAD9-8317-4658-AFCD-8B8354C5202AQ30242080-DABFB0A4-325C-43B1-AFE5-C5EA846FD7C0Q30833219-D7FDA5E6-2FB1-42CD-A6B5-95C8DE59B28FQ33499534-539CC70F-509F-4C4F-BE8F-84D260CFC8D4Q33717736-AAE7E49D-9325-42EA-B5B4-92E40C68BB1BQ34204054-78DCFCF6-D5F2-45E7-97E3-E05B993A558DQ34238676-A30E9ABF-1588-4A26-A7F4-88815BF03DEEQ34347583-95736E19-78AA-4368-A3B7-65DF7367D774Q36845821-1A7C18E2-70F8-428C-AFDB-76710F4271E8Q37123514-0A594670-DEA4-4814-A601-F281322EBFF0Q37369882-03AED187-84B6-44FA-BF69-CF379140A282Q37386291-B6B2CB97-8D0C-4337-B375-A52305BDE8A4Q37512822-3DBD6619-3908-4E04-B3DE-543EF1BC353DQ37608311-A525D789-7BDF-4296-B175-5ACDCD8F8E5BQ37643307-7A455B8D-A772-4F04-A058-AA6F0E11C7EAQ37951525-3476CB11-15C7-4D1B-AB36-0233F07DCC94Q38081975-0138B54F-C938-4BB3-92C5-B39DFE7B9EECQ40923728-7BBC027D-15D3-4E72-BF70-ED53593ED438Q41183186-BE9DA6C1-5AFB-41B6-B60C-BB3D403A3689Q41247832-D5372348-211E-494A-97BF-8E67649FE606Q41452212-80D6D329-8843-4B69-841B-9E23AF8F7A0CQ41877558-A2F3A485-4E5B-47AE-9E47-5CB2857A9597Q41969743-99D33899-BF95-4588-B15B-F7CA1C519A79Q43318399-863B12D5-C3C5-44CD-B2D4-AEA157B273DCQ45422576-CAAACD77-2719-490C-A367-083F37B8644AQ47144792-CBFE5D74-13C4-4E94-8092-9EE16E4CA076Q58583890-D1C99571-DE63-4636-89B9-D0A2F2DACC2F
P2860
Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Long-lasting protection of she ...... rtial heterologous protection.
@en
Long-lasting protection of she ...... rtial heterologous protection.
@nl
type
label
Long-lasting protection of she ...... rtial heterologous protection.
@en
Long-lasting protection of she ...... rtial heterologous protection.
@nl
prefLabel
Long-lasting protection of she ...... rtial heterologous protection.
@en
Long-lasting protection of she ...... rtial heterologous protection.
@nl
P2093
P1433
P1476
Long-lasting protection of she ...... artial heterologous protection
@en
P2093
B J Erasmus
D H Bishop
P304
P356
10.1016/0264-410X(94)90289-5
P407
P50
P577
1994-07-01T00:00:00Z